Pre-Donation Water Consumption
BehavioralConsumption of 500 ml of bottled water 30 minutes prior to donating
NCT Number: NCT00302900
Many individuals experience negative reactions when donating blood, including dizziness, lightheadedness, or fainting. Such reactions may discourage them from donating again. This study will evaluate the effectiveness of pre-donation water consumption and a muscle tensing exercise during donation to reduce negative reactions among new blood donors. This study will also evaluate whether reducing negative reactions increases the likelihood of donors returning to give blood in the future.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 2
Ohio University, Athens, Ohio, United States
Severe and potentially dangerous shortages in the blood supply are increasingly common in the United States. As the population ages and as more stringent donor eligibility restrictions are enforced, blood shortages are expected to worsen. One way to meet the increasing demand for blood is to recruit new blood donors. Ideally, these individuals would become lifelong donors, and contribute up to six times per year and up to hundreds of units of blood within a lifetime. Unfortunately, less than half of all new donors provide a second donation. Many individuals who donate blood experience dizziness, weakness, lightheadedness, or in severe cases, fainting. As a result of these negative reactions, many individuals never donate blood again. Preventing these reactions may be an effective way to encourage subsequent blood donations. The purpose of this study is to evaluate the effectiveness of consuming water prior to donation and performing a muscle tensing exercise during donation as ways to reduce negative reactions in new blood donors. The study's long-term goal is to provide blood collection agencies with simple and inexpensive strategies to prevent negative reactions and enhance donor retention.
This study will enroll American Red Cross blood donors who have donated blood no more than twice previously. Participants will be randomly assigned to one of the following four groups: 1) pre-donation water consumption and muscle tensing exercise during donation; 2) pre-donation water consumption; 3) pre-donation muscle tensing exercise; or 4) no treatment. Participant reactions will be assessed at the time of donation by self-report and phlebotomist ratings, as well as by self-report 24 hours following the donation. Participants' subsequent donation history will be tracked for two years by reviewing the American Red Cross national donor database.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Consumption of 500 ml of bottled water 30 minutes prior to donating
Alternating leg lifts at 10-second intervals during donation
Alternating leg lifts at 10-second intervals prior to insertion of the donation needle
Time frame: Measured within 30 minutes of donating
Time frame: Measured immediately following donation
Time frame: Measured 2 years post-donation
Time frame: Measured 24 hours post-donation
Time frame: Measured 24 hours post-donation
Ohio University
Other
Preventing Adverse Reactions in Novice Blood Donors
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06038708
Autonomic Nervous System Diseases, Consciousness Disorders
Bolzano, Italy
View Trial DetailsNCT05728255
Autonomic Nervous System Diseases, Cardiovascular Diseases
Marseille, France
View Trial DetailsNCT04972123
Autonomic Nervous System Diseases, Consciousness Disorders
Madison, Wisconsin, United States
View Trial DetailsNCT05729724
Ambulatory Blood Pressure Monitoring, Antihypertensive Drugs
Milan, MI, Italy
View Trial Details